Market Research Logo

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

About Sickle-cell Anemia

Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations.

TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Sickle-cell Anemia Therapeutics market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of the US FDA-approved drugs used for the treatment of sickle-cell anemia.

TechNavio's report, Sickle-cell Anemia Therapeutics Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Sickle-cell Anemia Therapeutics market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market..

Key Vendors

  • Bristol-Myers Squibb
  • Future Prominent Vendors
  • Baxter
  • Bluebird Bio
  • Daiichi Sankyo
  • Eli Lilly
  • Emmaus Medical
  • GlycoMimetics
  • HemaQuest Pharmaceuticals
  • Mast Therapeutics
  • Merck Sharp & Dohme
  • Pfizer
  • Selexys Pharmaceuticals
Market Driver
  • Unmet Medical Needs
  • For a full, detailed list, view our report
Market Challenge
  • Side Effects Associated with Current Therapies
  • For a full, detailed list, view our report
Market Trend
  • Increased Focus on Adult Patients
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

TechNavio Announces the Publication of its Research Report – Sickle-cell Anemia Therapeutics Market in the US 2015-2019

TechNavio recognizes the following companies as the key players in the Sickle-cell Anemia Therapeutics Market in the US: Bristol-Myers Squibb Co.

Other Prominent Vendors in the market are: Baxter, Bluebird Bio, Daiichi Sankyo, Eli Lilly, Emmaus Medical, GlycoMimetics, HemaQuest Pharmaceuticals, Mast Therapeutics, Merck Sharp & Dohme, Pfizer and Selexys Pharmaceuticals.

Commenting on the report, an analyst from TechNavio’s team said: “Increasing focus on adult patients is one key trend in this market, which is anticipated to provide better healthcare services to adult patients and improve their QoL.”

According to the report, a high degree of unmet medical needs in terms of safe, efficacious, and epilepsy-modifying treatments is one of the major drivers of this market. Any drug that can cater to these demands is expected to drive the market during the forecast period of 2014-2019. .

Further, the report states that the side effects associated with the current therapies are one of the major challenges faced by the market. The more side effects associated with a therapy, the lesser the compliance of patients, which consequently decreases the revenue generation of drugs in the market.Bristol-Myers Squibb, Baxter, Bluebird Bio, Daiichi Sankyo, Eli Lilly, Emmaus Medical, GlycoMimetics , HemaQuest Pharmaceuticals, Mast Therapeutics, Merck Sharp & Dohme, Pfizer, Selexys Pharmaceuticals

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offering
      • Table Product Offering for Sickle-cell Anemia Therapeutics Market in US
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Disease Overview
    • Table Normal erythrocytes and Sickle-shaped Erythrocytes
    • Table Impact of Sickled Erythrocytes on Blood Flow
    • Table Structure of Hemoglobin
    • Table Genetic Basis of Sickle-cell Anemia
    • Table Global Distribution of Sickle-cell Gene
    • Table Symptoms of Sickle-cell Disease
    • Table Inheritance Pattern of Sickle-cell Anemia
    • Table Blood Sample of Sickle-cell Disease Patients Before and After Stem Cell Transplantation
    • Table Laboratory Tests Recommended Before Initiation of Hydroxyurea Therapy
    • Table Facts for Hemoglobin Disorders
    • Table RuSH Project Sites
    • Table PHRESH: Primary Focus
  • Introduction
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Sickle-cell Anemia Therapeutics Market in US 2014-2019 (US$ million)
    • Five Forces Analysis
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Life Expectancy of Sickle-cell Disease Patients in US
    • Table Sickle-cell Disease Treatment Demonstration Program Regional Collaborative Technical Assistance: Aims of Funding
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Pipeline Analysis
    • Market Share Analysis 2013
  • Future Prominent Vendors
  • Key Vendor Analysis
    • Bristol-Myers Squibb
      • Key Facts
      • Business Overview
      • Key Product Offerings
        • Table Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
      • Revenue by Geography
        • Table Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report